Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE MedClean Technologies
New Leadership, Focused on Realizing Shareholder Value
BETHLEHEM, Pa., Feb. 28, 2013 /PRNewswire/ -- MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of technology designed for the efficient treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced that the Board of Directors has appointed a new Chairman and CEO.
Jay Bendis will return to his former role as Chairman of the board. Mr. Bendis previously served as Chairman and has been involved with MedClean as a Board Member since 2006.
"My goal is to help guide this company to delivering shareholder value," commented Mr. Bendis. "The company has evolved its business model and product offerings to create compelling opportunities in an underserved industry. Although the sales cycle has been longer than anticipated, and economic conditions have exacerbated those efforts, I am confident the pieces are in place to create value, and I look forward to reaching that goal."
John Accardi was promoted to CEO from Senior Vice President of Business Development.. While responsible for business development, the MedClean installed base has increased by 20% with new installs in California, Arkansas, Pennsylvania, Mexico, Puerto Rico and Iowa. Mr. Accardi's extensive management experience includes building domestic and international direct sales forces, as well as international partner recruitment and management. Mr. Accardi brings more than 25 years of broad operational experience in marketing, sales, business development, channel development and product development.
"This is an important time for MedClean Technologies, Inc.," commented Mr. Accardi. "Our Immediate focus is put strategies in place to enable us to bolster our balance sheet while improving our capital structure for potential growth activity. With the anticipated expansion of the ecommerce line, both Jay and I feel we will have the ability to serve the customers, vendors and shareholders well in the short term. The foundation to the next steps for MedClean were put in place under the previous CEO and as part of his team, I understand what the next steps for the company to move forward entail and I look forward to that challenge."
About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable healthcare providers and medical waste haulers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities now located in Bethlehem, Pennsylvania. Additional information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.
Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
©2012 PR Newswire. All Rights Reserved.